Diabetizer is a popular German-based healthcare technology company that is founded and maintained by Robin Hrassnigg. For the past several years, the company is working on the development of some reliable treatments for diabetes. As Hrassnigg himself is suffering from type 1 diabetes, he understands well how difficult it is to handle the symptoms of this disease in daily life.

Stats reveal that there are more than 387 million people that are experiencing trouble due to diabetes mellitus, a set of chronic diseases living considerable impact on the human body’s natural ability to use insulin. Experts advise following adequate techniques for the day-to-day management of disease symptoms and it is mainly focused on medication dosage, food intake, and diligent monitoring of blood sugar levels.

It is observed that diabetic patients that rely on handwritten medical records or some disconnected applications for tracking their health issues are usually at high risk of error. Furthermore, when doctors do not get proper insights into the patient’s disease history and overall health, it gets difficult to ensure the optimal treatment to deal with the symptoms. Unfortunately, wrong treatment for diabetes can lead to many other health complications such as nerve damage, heart disease, and vision issues.

Considering all these aspects of diabetic care and treatment, Hrassnigg and his team at Diabetizer has proposed a cloud-driven platform that can gather as well as analyze data automatically from wearable devices. This cloud-based access to patient’s health information can assist in reliable treatment in the long run. And the great news is that this cloud-based platform is designed by the famous technology company IBM.

IBM Cloud to help Diabetizer for improving diabetes treatment

As per the recent reports, IBM has announced to work in association with Diabetizer to leverage Bluemix, an open platform as a service, for building and deploying an innovative cloud-based application that could improve diabetic care all over the world. This app can help diabetic patients to access and aggregate health data using multiple devices from any corner of the world. Furthermore, it can apply advanced analytics for controlling the blood sugar levels to achieve precisely accurate conditions.

Bluemix is the largest cloud platform from Cloud Foundry Foundation. Its beta version was launched in the year 2014 and in the past 6 years, it has helped many start-ups including Diabetizer to utilize mobile resources in a more creative and innovative manner. Note that Diabetizer is the first most consumer of Bluemix and this collaboration shows a perfect example of how young companies can benefit from the global cloud infrastructure. The cloud system makes it easier to access the health history of patients on the go.

There is no doubt to say that diabetes is one of the top-ranked health issues in the world, therefore IBM and Diabetizer together are making efforts to change the way people care and manage diabetes. This modern analytics-driven app could connect seamlessly between web interfaces and mobile apps while ensuring enhanced precision and flexibility to patients. This new app can help patients to:

• Aggregate blood sugar, health, and nutritional data coming from different sources such as web apps and smartphone into one centralized portal. This centralized data store makes it easier to access data from anywhere in the world while simplifying the doctor-patient conversations and access to the patient records.
• The proposed system makes use of internet of things technology to integrate valuable biometric data from different wearable devices. It can further analyze the routine physical activity of the patients including variations in the blood sugar levels so that doctors can avail a complete view of the patient’s overall health.

Studies reveal that this cloud technology can provide enhanced flexibility to patients and medical health experts as well. The centralized data analytics system can provide powerful insights relevant to millions of patients all over the world. With this, the medical health community could work towards developing an accurate treatment to ensure enhanced comfort to the patients.

myDIABETIZER app for diabetic patients:

The myDIABETIZER app is designed to combine the blood glucose readings with the detailed professional documentation provided by diabetologists and doctors. The data can be imported automatically while highlighting key parameters specific to the patient's needs. Furthermore, the app synchronizes the readings obtained from the devices such as iBGStar that can measure the blood glucose of patients through smartphones directly.

myDIABETIZER app can collect real-time data from other famous fitness services such as Nutritionix, MapMy Fitness, Fitbit, and RunKeeper. This platform can create a centralized risk index based on specific patient data so that his/her health status can be kept under the scanner all the time. This platform offers incredible benefits for improving the overall quality of life while helping patients to manage their day-to-day illness levels. Other than this, myDIABETIZER also supports enhanced decision-making and on-the-go monitoring solutions as per the specific lifestyle of the patient. The caregivers can also access this data to understand the relationship between specific activities and changing blood sugar levels of the patient.

The monitoring and decision-making solutions for medical health problems are required to be highly accurate. Hrassnigg and his team have also focused on this factor to ensure reliable results with myDIABETIZER. This platform captures and delivers the most accurate data while driving clinical decisions in a more flexible and effective manner. Considering these aspects, patients, caregivers, and medical health can make better decisions about routine care procedures and potential treatments. Other than this, these aspects can be useful for patients to apply for life insurance for type 1 diabetes. This can be a useful decision for the entire family of the patient.

There is no doubt to say that the collaboration of IBM with the Diabetizer company has opened new scopes for growth and development in the medical health industry. The company has offered new treatment options to the medical health experts while helping caregivers to get instant updates about the health status of the patient on the go.